SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2151561

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2151561

Biophotonics Market Size, Share & Trends Analysis Report By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4950
Printable PDF & Excel (5-User License)
USD 5950
Printable PDF & Excel (Enterprise License)
USD 7950

Add to Cart

The global biophotonics market size was valued at USD 82.9 billion in 2025 and is projected to grow from USD 91.3 billion in 2026 to USD 180.2 billion in 2033, at a CAGR of 10.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 37.5% in 2025. Market growth is supported by the growing geriatric population, rising prevalence of chronic diseases, increasing government initiatives, healthcare modernization, and expanding integration of optical technologies across medical applications. Increasing adoption of photonic components in diagnostic and therapeutic devices is improving imaging performance, analytical sensitivity, and diagnostic accuracy. In addition, the growing use of biophotonics for environmental monitoring of water and food quality is broadening the application scope.

Technological advancements over the past decade and their increasing adoption across healthcare applications continue to support market expansion. The emergence of nanotechnology, combined with the growing demand for home-based point-of-care diagnostic devices, is creating new opportunities for biophotonic technologies. Continuous improvements in optical technologies developed for the aerospace and telecommunications industries are also contributing to innovations in medical photonics. In addition, public and private investments in research and development, including funding through initiatives such as the National Nanotechnology Initiative, are accelerating the development of advanced biophotonic technologies.

Machine learning is increasingly integrated into biophotonics to improve image analysis, particle detection, and data interpretation. Conventional microscopy images often contain low contrast, background noise, and indistinct boundaries, making manual identification and quantification of biological particles time-consuming and challenging. Machine learning algorithms enable automated detection and classification of individual particles by analyzing complex image patterns with greater accuracy and consistency. The ability to extract meaningful biological information from large imaging datasets is enhancing the performance of biophotonic technologies across biomedical research, diagnostics, and clinical applications.

Global Biophotonics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global biophotonics market report based on technology, application, end use, and region.

  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)

In-Vitro

In-Vivo

  • Application Outlook (Revenue, USD Billion, 2021 - 2033)

See-Through imaging

Microscopy

Inside Imaging

Spectro Molecular

Analytics Sensing

Light Therapy

Surface Imaging

Biosensors

  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)

Tests and Components

Medical Therapeutics

Medical Diagnostics

Non-medical Application

  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • Germany
    • UK
    • France

Asia Pacific

    • China
    • Japan
    • India
    • South Korea

Latin America

    • Brazil

Middle East and Africa (MEA)

    • United Arab Emirates
    • Saudi Arabia
    • South Africa
Product Code: 978-1-68038-871-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biophotonics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biophotonics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biophotonics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biophotonics Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. In-Vitro
    • 4.3.1. In-Vitro Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. In-Vivo
    • 4.4.1. In-Vivo Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Biophotonics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biophotonics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. See-Through Imaging
    • 5.3.1. See-Through Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Microscopy
    • 5.4.1. Microscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Inside Imaging
    • 5.5.1. Inside Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Spectro Molecular
    • 5.6.1. Spectro Molecular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Analytics Sensing
    • 5.7.1. Analytics Sensing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Light Therapy
    • 5.8.1. Light Therapy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Surface Imaging
    • 5.9.1. Surface Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Biosensors
    • 5.10.1. Biosensors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Biophotonics Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Biophotonics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Teste and Components
    • 6.3.1. Taste and Components Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Medical Therapeutics
    • 6.4.1. Medical Therapeutics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Medical Diagnostic
    • 6.5.1. Medical Diagnostic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Non-Medical Application
    • 6.6.1. Non-Medical Application Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Biophotonics Market: Regional Estimates & Trend Analysis

  • 7.1. Biophotonics Market Share, By Region, 2023 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Biophotonics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Affymetrix Inc. (Thermo Fisher Scientific Inc.)
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. BD (Becton, Dickinson and Company)
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. ZEISS Group
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Olympus Corporation
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Hamamatsu Photonics K.K
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Zecotek Photonics Inc.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. IDEX
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. IPG Photonics Corporation
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. TOSHIBA CORPORATION
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Oxford Instruments
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. PerkinElmer Inc.
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!